Innovus Pharma Revenue, Profits - INNV Quarterly Income Statement

Add to My Stocks
$0.12 $0 (0%) INNV stock closing price Sep 18, 2018 (Closing)

Looking at financial statements, along with the Innovus Pharma stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the INNV stock is bound to reflect the impact of the QOQ growth of 61.01%. Revenue for year 2018 Q2 is $7.31M and has increased from $4.54M quarter on quarter as is evident when you compare the latest figures in the latest Innovus Pharma profit and loss statement with those of the prior corresponding period. Also see Innovus Pharma assets and Innovus Pharma free cash flow for a complete valuation of INNV stock.

View and download details of revenue and profits for Innovus Pharma for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Innovus Pharma Revenues or Net Sales
Cost Of Goods Sold (COGS)1.34M---------
Innovus Pharma Gross Profit
Research & Development Expense----------
Selling General & Admin Expense7.45M4.99M2.96M2.94M2.73M3.39M3.23M3.75M1.19M1.32M
Income Before Depreciation Depletion Amortization-1.5M-1.32M-1.11M-1.21M-1.12M-1.65M-1.94M-2.24M-0.44M-1.21M
Depreciation Depletion Amortization----------
Non Operating Income-0.02M-0.25M-0.29M-0.01M--0.32M-0.75M1.54M-2.04M-
Interest Expense-------3.72M1.87M-
Innovus Pharma Pretax Income
Provision for Income Taxes----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-1.84M-1.83M-1.5M-1.33M-1.13M-2.55M-3.36M-4.43M-4.36M-1.56M
Extraordinary Items & Discontinued Operations----------
Innovus Pharma Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS205.11M186.93M174.58M161.59M160M135.1M116.77M104.97M85.4M68.37M
Average Shares used to compute Basic EPS205.11M186.93M174.58M161.59M160M135.1M116.77M104.97M85.4M68.37M
Income Before Nonrecurring Items-1.8M-1.83M-1.19M-0.83M-0.83M-2.55M-1.9M-0.83M-4.36M-1.56M
Income from Nonrecurring Items-0.04M--0.31M-0.5M-0.3M--1.47M-3.6M--
Innovus Pharma Earnings Per Share Basic Net
Innovus Pharma Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.01-0.01-0.01-0.01-0.01-0.02-0.02-0.01-0.05-0.02
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Innovus Pharma stock analysis involves checking at least a few of the important things like:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: Innovus Pharma revenue chart, implies that the company is growing. It has been the case with Innovus Pharma. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: Most businesses like Innovus Pharma try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called the profit and loss statement. Apart from the INNV income statement, one can check the Innovus Pharma historical stock prices to check how the price has moved with time.

Innovus Pharma Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield